| Emcure Pharmaceuticals Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 544210 |
NSE Symbol : EMCURE |
P/E(TTM) : 67.24 |
|
ISIN Demat : INE168P01015 |
Div & Yield% : 0.20 |
EPS(TTM) : 22.83 |
|
Book Value(₹) : 169.51 |
Market Cap(₹Cr) : 29,103.18 |
Face Value(₹) : 10.00 |
| Particulars | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|
| Gross Sales | 1,418.31 | 1,260.60 | 1,096.57 | 1,278.19 | 1,028.81 | 1,104.63 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 1,418.31 | 1,260.60 | 1,096.57 | 1,278.19 | 1,028.81 | 1,104.63 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 138.30 | 22.75 | 21.52 | 22.40 | 19.41 | 49.06 |
| Total Income | 1,556.61 | 1,283.36 | 1,118.10 | 1,300.58 | 1,048.22 | 1,153.69 |
| Total Expenditure | 1,146.95 | 1,036.01 | 872.07 | 1,033.55 | 904.40 | 946.60 |
| PBIDT | 409.65 | 247.34 | 246.02 | 267.03 | 143.83 | 207.09 |
| Interest | 33.15 | 27.71 | 20.54 | 24.07 | 19.93 | 31.40 |
| PBDT | 376.50 | 219.63 | 225.49 | 242.96 | 123.90 | 175.69 |
| Depreciation | 62.14 | 61.74 | 59.82 | 56.91 | 56.65 | 56.34 |
| Tax | 64.89 | 45.98 | 44.00 | 63.59 | 6.53 | 29.68 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | -9.38 | -5.71 | -1.12 | -17.10 | 10.52 | 2.76 |
| Reported Profit After Tax | 258.85 | 117.62 | 122.79 | 139.56 | 50.20 | 86.92 |
| Extra-ordinary Items | -23.13 | 0.00 | -2.57 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 281.98 | 117.62 | 125.36 | 139.56 | 50.20 | 86.92 |
| EPS (Unit Curr.) | 13.65 | 6.21 | 6.48 | 7.37 | 2.65 | 4.62 |
| EPS (Adj) (Unit Curr.) | 13.65 | 6.21 | 6.48 | 7.37 | 2.65 | 4.62 |
| Calculated EPS (Unit Curr.) | 13.65 | 6.20 | 6.48 | 7.37 | 2.65 | 4.60 |
| Calculated EPS (Adj) (Unit Curr.) | 13.65 | 6.20 | 6.48 | 7.37 | 2.65 | 4.60 |
| Calculated EPS (Ann.) (Unit Curr.) | 54.62 | 24.82 | 25.92 | 29.46 | 10.60 | 18.39 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 54.62 | 24.82 | 25.92 | 29.46 | 10.60 | 18.39 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 30.00 | 0.00 | 0.00 |
| Equity | 189.57 | 189.57 | 189.51 | 189.48 | 189.43 | 189.10 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 28.88 | 19.62 | 22.44 | 20.89 | 13.98 | 18.75 |
| PBDTM(%) | 26.55 | 17.42 | 20.56 | 19.01 | 12.04 | 15.90 |
| PATM(%) | 18.25 | 9.33 | 11.20 | 10.92 | 4.88 | 7.87 |